Very low dose perindopril/indapamide combination fully protects obese rat kidney structure and function.

被引：0

作者：

Renaud, IM

Chainey, A

Chevalier, J

Plante, GE

机构：

[1] Hop Broussais, INSERM, U430, Paris, France

[2] Fac Med, Pharmacol Inst, Sherbrooke, PQ, Canada

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：759A / 759A

页数：1

共 50 条

[41] Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure
Safar, ME
Myers, MG
Leenen, F
Asmar, R
[J]. JOURNAL OF HYPERTENSION, 2002, 20 (08) : 1653 - 1661
[42] Efficacy and acceptability of the fixed low-dose perindopril-indapamide combination as first-line therapy in hypertension
Chalmers, J
[J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0L) : L20 - L25
[43] Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects
de Luca, N
Asmar, RG
London, GM
O'Rourke, MF
Safar, ME
[J]. JOURNAL OF HYPERTENSION, 2004, 22 (08) : 1623 - 1630
[44] Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study
Mallion, JM
Chastang, C
Unger, P
[J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2000, 22 (01) : 23 - 32
[45] Treatment based on a very low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive Type 2 diabetic patients: the PREMIER study
Viberti, G
Mogensen, C
Ritz, E
Halimi, S
Ruilope, L
Jermendy, G
Widimsky, J
Sareli, P
Taton, J
Erdogan, G
Rull, J
[J]. DIABETOLOGIA, 2002, 45 : A65 - A66
[46] Benefit of a low dose combination of Perindopril and Indapamide based treatment on albuminuria regression in hypertensive type 2 diabetics; The premier study
Viberti, G
Mogensen, CE
Halimi, S
Ritz, E
Ruilope, L
Jermendy, G
Widimsky, J
[J]. DIABETES, 2002, 51 : A186 - A186
[47] Antihypertensive efficacy and safety of first-line low-dose combination perindopril/indapamide (noliprel) in daily medical practice
Netchessova, T. A.
Lollini, V. A.
Mitkovskaya, N. P.
Dolgoshei, T. S.
Stankevich, F. M.
[J]. JOURNAL OF HYPERTENSION, 2007, 25 : S372 - S372
[48] EFFICACY AND TOLERABILITY OF A FIXED LOW-DOSE COMBINATION PERINDOPRIL/INDAPAMIDE AS INITIAL TREATMENT IN PRIMARY ARTERIAL HYPERTENSION: THE START STUDY
Vintila, M. M.
Baluta, M. M.
Lighezan, D.
Kulcsar, I.
[J]. JOURNAL OF HYPERTENSION, 2010, 28 : E282 - E282
[49] Fixed very-low-dose combination perindopril 2 mg/indapamide 0.625 mg in the treatment of essential arterial hypertension in very elderly patients (≥75 years):: Evaluation over 3 months
Castaigne, A
Chalmers, J
Morgan, T
[J]. JOURNAL OF HYPERTENSION, 2000, 18 : S17 - S17
[50] Efficacy of a very low-dose Perindopril 2 mg/Indapamide 0.625 mg on cardiac hypertrophy in hypertensive patients: The Reason project
De Luca, N
Safar, ME
Asmar, R
Battegay, E
Benetos, A
De Leeuw, PW
Duprez, D
Fitzgerald, D
Hedner, T
Hitzenberger, G
London, G
Mallion, JM
O'Brien, E
Ollivier, JP
O'Rourke, MF
Polonia, J
Rahn, KH
Romero, R
Sever, P
Trimarco, B
[J]. JOURNAL OF HYPERTENSION, 2002, 20 : S164 - S164

← 1 2 3 4 5 →